Autosomal recessive cerebellar ataxias

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Palau, Francesc ^a,b   Espinós, Carmen ^a,b  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABETALIPOPROTEINEMIA; ADOLESCENT; ADULT; ALPHA TOCOPHEROL DEFICIENCY; BRAIN; CEREBELLAR ATAXIA; CEREBROTENDINOUS XANTHOMATOSIS; CHILD; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; DIFFERENTIAL DIAGNOSIS; DISORDERS OF DNA SYNTHESIS AND REPAIR; FRIEDREICH ATAXIA; GENETICS; HUMAN; INFANT; MIDDLE AGED; MULTIPLE MALFORMATION SYNDROME; NEWBORN; PRESCHOOL CHILD; RECESSIVE GENE; REFSUM DISEASE; REVIEW; SPINOCEREBELLAR DEGENERATION; SYNDROME;

ABETALIPOPROTEINEMIA; ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; BRAIN; CEREBELLAR ATAXIA; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; DNA REPAIR-DEFICIENCY DISORDERS; FRIEDREICH ATAXIA; GENES, RECESSIVE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; REFSUM DISEASE; SPINOCEREBELLAR DEGENERATIONS; SYNDROME; VITAMIN E DEFICIENCY; XANTHOMATOSIS, CEREBROTENDINOUS; YOUNG ADULT;

EID: 34248181247     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-47     Document Type: Review

References (207)

1. T Klockgether, Handbook of Ataxia Disorders New York: Marcel Dekker, Inc 2000
2. The complex clinical and genetic classification of inherited ataxias II. Autosomal recessive ataxias. S Di Donato C Gellera C Mariotti, Neurol Sci 2001 22 219 228 10.1007/s100720100017 11731874
3. State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis. T Gasser S Bressman A Durr J Higgins T Klockgether RH Myers, Mov Disord 2003 18 3 18 10.1002/mds.10338 12518296
4. AE Harding, Hereditary ataxias and related disorders Edinburgh: Churchill-Livingstone 1984
5. Clinical features and classification of inherited ataxias. AE Harding, Adv Neurol 1993 61 1 14 8421960
6. Rare forms of autosomal recessive neurodegenerative ataxia. M Koenig, Semin Pediatr Neurol 2003 10 183 192 10.1016/S1071-9091(03)00027-5 14653406
7. A pathogenetic classification of hereditary ataxias: is the time ripe? G De Michele G Coppola S Cocozza A Filla, J Neurol 2004 251 913 922 10.1007/s00415-004-0484-2 15316795
8. Cerebello-oculo-renal syndromes including Arima, Senior-Loken and COACH syndromes: more than just variants of Joubert syndrome. D Satran ME Pierpont WB Dobyns, Am J Med Genet 1999 86 459 469 10.1002/(SICI)1096-8628(19991029)86: 5<459::AID-AJMG12>3.0.CO;2-C 10508989
9. Molar tooth sign of the midbrain-hindbrain junction: occurrence in multiple distinct syndromes. JG Gleeson LC Keeler MA Parisi SE Marsh PF Chance IA Glass JM Graham Jr BL Maria AJ Barkovich WB Dobyns, Am J Med Genet A 2004 125 125 134 10.1002/ajmg.a.20437 14981712
10. Homozygosity mapping in families with Joubert syndrome identifies a locus on chromosome 9q34.3 and evidence for genetic heterogeneity. K Saar L Al-Gazali L Sztriha F Rueschendorf M Nur-E-Kamal A Reis R Bayoumi, Am J Hum Genet 1999 65 1666 1671 10577920 10.1086/302655
11. Linkage analysis in families with Joubert syndrome plus oculo-renal involvement identifies the CORS2 locus on chromosome 11p12-q13.3. LC Keeler SE Marsh EP Leeflang CG Woods L Sztriha L Al-Gazali A Gururaj JG Gleeson, Am J Hum Genet 2003 73 656 662 12917796 10.1086/378206
12. Description, nomenclature, and mapping of a novel cerebello-renal syndrome with the molar tooth malformation. EM Valente DC Salpietro F Brancati E Bertini T Galluccio G Tortorella S Briuglia B Dallapiccola, Am J Hum Genet 2003 73 663 670 12908130 10.1086/378241
13. Homozygosity mapping of a third Joubert syndrome locus to 6q23. C Lagier-Tourenne E Boltshauser N Breivik M Gribaa C Betard C Barbot M Koenig, J Med Genet 2004 41 273 277 10.1136/jmg.2003.014787 15060101
14. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. RJ Ferland W Eyaid RV Collura LD Tully RS Hill D Al-Nouri A Al-Rumayyan M Topcu G Gascon A Bodell YY Shugart M Ruvolo CA Walsh, Nat Genet 2004 36 1008 1013 10.1038/ng1419 15322546
15. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome. MA Parisi CL Bennett ML Eckert WB Dobyns JG Gleeson DW Shaw R McDonald A Eddy PF Chance IA Glass, Am J Hum Genet 2004 75 82 91 15138899 10.1086/421846
16. NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. M Castori EM Valente MA Donati S Salvi E Fazzi E Procopio T Galluccio F Emma B Dallapiccola E Bertini Italian MTS Study Group, J Med Genet 2005 42 e9 10.1136/jmg.2004.027375 15689444
17. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. EM Valente JL Silhavy F Brancati G Barrano SR Krishnaswami M Castori MA Lancaster E Boltshauser L Boccone L Al-Gazali E Fazzi S Signorini CM Louie E Bellacchio International Joubert Syndrome Related Disorders Study Group E Bertini B Dallapiccola JG Gleeson, Nat Genet 2006 38 623 625 10.1038/ng1805 16682970
18. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. JA Sayer EA Otto JF O'Toole G Nurnberg MA Kennedy C Becker HC Hennies J Helou M Attanasio BV Fausett B Utsch H Khanna Y Liu I Drummond I Kawakami T Kusakabe M Tsuda L Ma H Lee RG Larson SJ Allen CJ Wilkinson EA Nigg C Shou C Lillo DS Williams B Hoppe MJ Kemper T Neuhaus MA Parisi IA Glass M Petry A Kispert J Gloy A Ganner G Walz X Zhu D Goldman P Nurnberg A Swaroop MR Leroux F Hildebrandt, Nat Genet 2006 38 674 681 10.1038/ng1786 16682973
19. A cerebellar ataxia locus identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands. A Nystuen PJ Benke J Merren EM Stone VC Sheffield, Hum Mol Genet 1996 5 525 531 10.1093/hmg/5.4.525 8845847
20. Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. JM Bomar PJ Benke EL Slattery R Puttagunta LP Taylor E Seong A Nystuen W Chen RL Albin PD Patel RA Kittles VC Sheffield M Burmeister, Nat Genet 2003 35 264 269 10.1038/ng1255 14556008
21. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. M Ben Hamida S Belal G Sirugo C Ben Hamida K Panayides P Ionannou J Beckmann JL Mandel F Hentati M Koenig, Neurology 1993 43 2179 2183 8232925
22. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. M Arita Y Sato A Miyata T Tanabe E Takahashi HJ Kayden H Arai K Inoue, Biochem J 1995 306 437 443 7887897
23. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. K Ouahchi M Arita H Kayden F Hentati M Ben Hamida R Sokol H Arai K Inoue JL Mandel M Koenig, Nat Genet 1995 9 141 145 10.1038/ng0295-141 7719340
24. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. L Cavalier K Ouahchi HJ Kayden S Di Donato L Reutenauer JL Mandel M Koenig, Am J Hum Genet 1998 62 301 310 9463307 10.1086/301699
25. Ataxia with isolated vitamin E deficiency. M Koenig, Handbook of Ataxia Disorders New York: Marcel Dekker, Inc, Klockgether T, 2000 223 234
26. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. T Gotoda M Arita H Arai K Inoue T Yokota Y Fukuo Y Yazaki N Yamada, N Engl J Med 1995 333 1313 1318 10.1056/NEJM199511163332003 7566022
27. Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. T Yokota T Shiojiri T Gotoda M Arita H Arai T Ohga T Kanda J Suzuki T Imai H Matsumoto S Harino M Kiyosawa H Mizusawa K Inoue, Ann Neurol 1997 41 826 832 10.1002/ana.410410621 9189046
28. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. JR Wetterau LP Aggerbeck ME Bouma C Eisenberg A Munck M Hermier J Schmitz G Gay DJ Rader RE Gregg, Science 1992 258 999 1001 10.1126/science.1439810 1439810
29. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. D Sharp L Blinderman KA Combs B Kienzle B Ricci K Wager-Smith CM Gil CW Turck ME Bouma DJ Rader, Nature 1993 365 65 69 10.1038/365065a0 8361539
30. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. CC Shoulders DJ Brett JD Bayliss TM Narcisi A Jarmuz TT Grantham PR Leoni S Bhattacharya RJ Pease PM Cullen, Hum Mol Genet 1993 2 2109 2116 8111381
31. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. TM Narcisi CC Shoulders SA Chester J Read DJ Brett GB Harrison TT Grantham MF Fox S Povey TW de Bruin, Am J Hum Genet 1995 57 1298 1310 8533758
32. Familial hypobetalipoproteinemia. MF Linton RV Farese Jr SG Young, J Lipid Res 1993 34 521 541 8496659
33. A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus. K Ohashi S Ishibashi M Yamamoto J Osuga Y Yazaki S Yukawa N Yamada, Arterioscler Thromb Vasc Biol 1998 18 1330 1334 9714141
34. Abetalipoproteinemia. A Kohlschütter, Handbook of Ataxia Disorders New York: Marcel Dekker, Inc, Klockgether T, 2000 205 221
35. Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan origin. VM Berginer D Abeliovich, Am J Med Genet 1981 10 151 157 10.1002/ajmg.1320100209 7315872
36. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. MH Moghadasian, Clin Invest Med 2004 27 42 50 15061585
37. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. JJ Cali CL Hsieh U Francke DW Russell, J Biol Chem 1991 266 7779 7783 2019602
38. Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. MH Lee S Hazard JD Carpten S Yi J Cohen GT Gerhardt G Salen SB Patel, J Lipid Res 2001 42 159 169 11181744
39. Cerebrotendinous Xanthomatosis. V Meiner E Laeitersdorf, Handbook of ataxias New York: Marcel Dekker, Inc, Klockgether T, 2000 257 269
40. Identification of PAHX, a Refsum disease gene. SJ Mihalik JC Morrell D Kim KA Sacksteder PA Watkins SJ Gould, Nat Genet 1997 17 185 189 10.1038/ng1097-185 9326939
41. Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease. GA Jansen EM Hogenhout S Ferdinandusse HR Waterham R Ofman C Jakobs OH Skjeldal RJ Wanders, Hum Mol Genet 2000 9 1195 1200 10.1093/hmg/9.8.1195 10767344
42. Phytanoyl-coenzyme A hydroxylase deficiency - the enzyme defect in Refsum's disease. GA Jansen RJ Wanders PA Watkins SJ Mihalik, N Engl J Med 1997 337 133 134 10.1056/NEJM199707103370215 9221344
43. Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). GA Jansen HR Waterham RJ Wanders, Hum Mutat 2004 23 209 218 10.1002/humu.10315 14974078
44. The Refsum disease marker phytanic acid, a branched chain fatty acid, affects Ca2+ homeostasis and mitochondria, and reduces cell viability in rat hippocampal astrocytes. S Kahlert P Schonfeld G Reiser, Neurobiol Dis 2005 18 110 118 10.1016/j.nbd.2004.08.010 15649701
45. Influence of plasma phytanic acid leveks in Refsum's disease at chromosome 6p22-24 [abstract]. ASHT Wierzbicki P Lumb A Sankaralingam Z Morrish F Patel MC Sidey FB Gibberd, J Inherit Metab Dis 2000 23 Suppl 1 259
46. Identification of PEX7 as the second gene involved in Refsum disease. DM Van den Brink P Brites J Haasjes AS Wierzbicki J Mitchell M Lambert-Hamill J de Belleroche GA Jansen HR Waterham RJ Wanders, Am J Hum Genet 2003 72 471 477 12522768 10.1086/346093
47. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. N Braverman G Steel C Obie A Moser H Moser SJ Gould D Valle, Nat Genet 1997 15 369 376 10.1038/ng0497-369 9090381
48. Ataxia Telangiectasia. N Jabado P Concannon RA Gatti, Handbook of ataxias New York: Marcel Dekker, Inc, Klockgether T, 2000 164 190
49. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. RA Gatti I Berkel E Boder G Braedt P Charmley P Concannon F Ersoy T Foroud NG Jaspers K Lange, Nature 1988 336 577 580 10.1038/336577a0 3200306
50. Genetic haplotyping of ataxia-telangiectasia families localizes the major gene to an approximately 850 kb region on chromosome 11q23.1. RA Gatti E Lange G Rotman X Chen N Uhrhammer T Liang S Chiplunkar L Yang N Udar S Dandekar, Int J Radiat Biol 1994 66 S57 62 7836853
51. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. K Savitsky A Bar-Shira S Gilad G Rotman Y Ziv L Vanagaite DA Tagle S Smith T Uziel S Sfez, Science 1995 268 1749 1753 10.1126/science.7792600 7792600
52. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. G Chen E Lee, J Biol Chem 1996 271 33693 33697 10.1074/jbc.271.52.33693 8969240
53. The Ataxia-telangiectasia Mutation Database. http://www.vmresearch.org/ atm.htm
54. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. SG Becker-Catania G Chen MJ Hwang Z Wang X Sun O Sanal E Bernatowska-Matuszkiewicz L Chessa EY Lee RA Gatti, Mol Genet Metab 2000 70 122 133 10.1006/mgme.2000.2998 10873394
55. Atypical clinical presentation of ataxia telangiectasia. PJ Willems BC Van Roy WJ Kleijer M Van der Kraan JJ Martin, Am J Med Genet 1993 45 777 782 10.1002/ajmg.1320450624 8456862
56. Genotype-phenotype relationships in ataxia-telangiectasia and variants. S Gilad L Chessa R Khosravi P Russell Y Galanty M Piane RA Gatti TJ Jorgensen Y Shiloh A Bar-Shira, Am J Hum Genet 1998 62 551 561 9497252 10.1086/301755
57. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. GS Stewart RS Maser T Stankovic DA Bressan MI Kaplan NG Jaspers A Raams PJ Byrd JH Petrini AM Taylor, Cell 1999 99 577 587 10.1016/S0092-8674(00)81547-0 10612394
58. A family showing no evidence of linkage between the ataxia telangiectasia gene and chromosome 11q22-23. D Hernandez CM McConville M Stacey CG Woods MM Brown P Shutt G Rysiecki AM Taylor, J Med Genet 1993 30 135 140 8445618
59. Ataxia without telangiectasia masquerading as benign hereditary chorea. C Klein GK Wenning NP Quinn CD Marsden, Mov Disord 1996 11 217 220 10.1002/mds.870110217 8684395
60. Phenotypic variability of aprataxin gene mutations. C Tranchant M Fleury MC Moreira M Koenig JM Warter, Neurology 2003 60 868 870 12629250
61. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. I Le Ber MC Moreira S Rivaud-Pechoux C Chamayou F Ochsner T Kuntzer M Tardieu G Said MO Habert G Demarquay C Tannier JM Beis A Brice M Koenig A Durr, Brain 2003 126 2761 2772 10.1093/brain/awg283 14506070
62. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations. H Shimazaki Y Takiyama K Sakoe K Ikeguchi K Niijima J Kaneko M Namekawa T Ogawa H Date S Tsuji I Nakano M Nishizawa, Neurology 2002 59 590 595 12196655
63. Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. C Barbot P Coutinho R Chorao C Ferreira J Barros I Fineza K Dias J Monteiro A Guimaraes P Mendonca M do Ceu Moreira J Sequeiros, Arch Neurol 2001 58 201 205 10.1001/archneur.58.2.201 11176957
64. Homozygosity mapping of Portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity. MC Moreira C Barbot N Tachi N Kozuka P Mendonca J Barros P Coutinho J Sequeiros M Koenig, Am J Hum Genet 2001 68 501 508 11170899 10.1086/318191
65. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. CJ Whitehouse RM Taylor A Thistlethwaite H Zhang F Karimi-Busheri DD Lasko M Weinfeld KW Caldecott, Cell 2001 104 107 117 10.1016/S0092-8674(01)00195-7 11163244
66. The novel human gene aprataxin is directly involved in DNA single-strand-break repair. P Mosesso M Piane F Palitti G Pepe S Penna L Chessa, Cell Mol Life Sci 2005 62 485 91 10.1007/s00018-004-4441-0 15719174
67. Aprataxin, a novel protein that protects against genotoxic stress. N Gueven OJ Becherel AW Kijas P Chen O Howe JH Rudolph R Gatti H Date O Onodera G Taucher-Scholz MF Lavin, Hum Mol Genet 2004 13 1081 1093 10.1093/hmg/ddh122 15044383
68. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. I Le Ber N Bouslam S Rivaud-Pechoux J Guimaraes A Benomar C Chamayou C Goizet MC Moreira S Klur M Yahyaoui Y Agid M Koenig G Stevanin A Brice A Durr, Brain 2004 127 759 767 10.1093/brain/awh080 14736755
69. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. MC Moreira S Klur M Watanabe AH Nemeth I Le Ber JC Moniz C Tranchant P Aubourg M Tazir L Schols M Pandolfo JB Schulz J Pouget P Calvas M Shizuka-Ikeda M Shoji M Tanaka L Izatt CE Shaw A M'Zahem E Dunne P Bomont T Benhassine N Bouslam G Stevanin A Brice J Guimaraes P Mendonca C Barbot P Coutinho J Sequeiros A Durr JM Warter M Koenig, Nat Genet 2004 36 225 227 10.1038/ng1303 14770181
70. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). YZ Chen CL Bennett HM Huynh IP Blair I Puls J Irobi I Dierick A Abel ML Kennerson BA Rabin GA Nicholson M Auer-Grumbach K Wagner P De Jonghe JW Griffin KH Fischbeck V Timmerman DR Cornblath PF Chance, Am J Hum Genet 2004 74 1128 1135 15106121 10.1086/421054
71. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. H Takashima CF Boerkoel J John GM Saifi MA Salih D Armstrong Y Mao FA Quiocho BB Roa M Nakagawa DW Stockton JR Lupski, Nat Genet 2002 32 267 272 10.1038/ng987 12244316
72. Nucleotide excision repair. Its relation to human disease. LH Thompson, DNA repair in higher eukaryotes Totowa: NJ: Human Press, Nickoloff JA, Hoekstra M, 1998 2 335 393
73. Xeroderma pigmentosum. J Norgauer M Idzko E Panther O Hellstern Y Herouy, Eur J Dermatol 2003 13 4 9 12609773
74. Xeroderma pigmentosum and Coackayne sindrome. JE Cleaver KH Kraemer, The metabolic and molecular bases of inherited disease New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, 1995 2 4393 4419
75. Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. DL Svoboda LP Briley JM Vos, Cancer Res 1998 58 2445 2448 9622087
76. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. G Geoffroy A Barbeau G Breton B Lemieux M Aube C Leger JP Bouchard, Can J Neurol Sci 1976 3 279 286 1087179
77. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. AE Harding, Brain 1981 104 589 620 7272714
78. Clinical and genetic abnormalities in patients with Friedreich's ataxia. A Durr M Cossee Y Agid V Campuzano C Mignard C Penet JL Mandel A Brice M Koenig, N Engl J Med 1996 335 1169 1175 10.1056/NEJM199610173351601 8815938
79. Friedreich's ataxia. Revision of the phenotype according to molecular genetics. L Schols G Amoiridis H Przuntek G Frank JT Epplen C Epplen, Brain 1997 120 2131 2140 10.1093/brain/120.12.2131 9448568
80. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis. F Palau, Int J Mol Med 2001 7 581 589 11351269
81. apping of mutation causing Friedreich's ataxia to human chromosome 9. S Chamberlain J Shaw A Rowland J Wallis S South Y Nakamura A von Gabain M Farrall R Williamson, Nature 1988 334 M248 250 10.1038/334248a0
82. A family segregating a Friedreich ataxia phenotype that is not linked to the FRDA locus. P Smeyers E Monros J Vilchez J Lopez-Arlandis F Prieto F Palau, Hum Genet 1996 97 824 828 8641704
83. Locus heterogeneity in Friedreich ataxia. M Kostrzewa T Klockgether MS Damian U Muller, Neurogenetics 1997 1 43 47 10.1007/s100480050007 10735274
84. Mapping of the second Friedreich's ataxia (FRDA2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity. K Christodoulou F Deymeer P Serdaroglu C Ozdemir M Poda DM Georgiou P Ioannou M Tsingis E Zamba LT Middleton, Neurogenetics 2001 3 127 132 10.1007/s100480100112 11523563
85. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. V Campuzano L Montermini MD Molto L Pianese M Cossee F Cavalcanti E Monros F Rodius F Duclos A Monticelli F Zara J Canizares H Koutnikova SI Bidichandani C Gellera A Brice P Trouillas G De Michele A Filla R De Frutos F Palau PI Patel S Di Donato JL Mandel S Cocozza M Koenig M Pandolfo, Science 1996 271 1423 1427 10.1126/science.271.5254.1423 8596916
86. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. H Koutnikova V Campuzano F Foury P Dolle O Cazzalini M Koenig, Nat Genet 1997 16 345 351 10.1038/ng0897-345 9241270
87. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. E Monros MD Molto F Martinez J Canizares J Blanca JJ Vilchez F Prieto R de Frutos F Palau, Am J Hum Genet 1997 61 101 110 9245990
88. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. V Campuzano L Montermini Y Lutz L Cova C Hindelang S Jiralerspong Y Trottier SJ Kish B Faucheux P Trouillas FJ Authier A Durr JL Mandel A Vescovi M Pandolfo M Koenig, Hum Mol Genet 1997 6 1771 1780 10.1093/hmg/6.11.1771 9302253
89. Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. N Sakamoto K Ohshima L Montermini M Pandolfo RD Wells, J Biol Chem 2001 276 27171 27177 10.1074/jbc.M101879200 11340071
90. Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. K Ohshima L Montermini RD Wells M Pandolfo, J Biol Chem 1998 273 14588 14595 10.1074/jbc.273.23.14588 9603975
91. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. SI Bidichandani T Ashizawa PI Patel, Am J Hum Genet 1998 62 111 121 9443873 10.1086/301680
92. Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. SI Bidichandani T Ashizawa PI Patel, Am J Hum Genet 1997 60 1251 1256 9150176
93. Frataxin fracas. M Cossee V Campuzano H Koutnikova K Fischbeck JL Mandel M Koenig SI Bidichandani PI Patel MD Molte J Canizares R De Frutos L Pianese F Cavalcanti A Monticelli S Cocozza L Montermini M Pandolfo, Nat Genet 1997 15 337 338 10.1038/ng0497-337 9090376
94. The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene. SM Forrest M Knight MB Delatycki D Paris R Williamson J King L Yeung N Nassif GA Nicholson, Neurogenetics 1998 1 253 257 10.1007/s100480050037 10732799
95. Identification of a missense mutation in a Friedreich's ataxia patient: implications for diagnosis and carrier studies. C Bartolo JR Mendell TW Prior, Am J Med Genet 1998 79 396 399 10.1002/(SICI)1096-8628(19981012)79:5<396:: AID-AJMG13>3.0.CO;2-M 9779809
96. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. M Cossee A Durr M Schmitt N Dahl P Trouillas P Allinson M Kostrzewa A Nivelon-Chevallier KH Gustavson A Kohlschutter U Muller JL Mandel A Brice M Koenig F Cavalcanti A Tammaro G De Michele A Filla S Cocozza M Labuda L Montermini J Poirier M Pandolfo, Ann Neurol 1999 45 200 206 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U 9989622
97. Mutation of the start codon in the FRDA1 gene: linkage analysis of three pedigrees with the ATG to ATT transversion points to a unique common ancestor. C Zuhlke F Laccone M Cossee A Kohlschutter M Koenig E Schwinger, Hum Genet 1998 103 102 105 10.1007/s004390050791 9737785
98. Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients. M De Castro J Garcia-Planells E Monros J Canizares R Vazquez-Manrique JJ Vilchez M Urtasun M Lucas G Navarro G Izquierdo MD Molto F Palau, Hum Genet 2000 106 86 92 10.1007/s004399900201 10982187
99. Identification of three novel frameshift mutations in patients with Friedreich's ataxia. MA Pook SA Al-Mahdawi NH Thomas R Appleton A Norman R Mountford S Chamberlain, J Med Genet 2000 37 E38 10.1136/jmg.37.11.e38 11073547
100. Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction. TJ Gibson EV Koonin G Musco A Pastore P Bork, Trends Neurosci 1996 19 465 468 10.1016/S0166-2236(96)20054-2 8931268
101. dfh is a Drosophila homolog of the Friedreich's ataxia disease gene. J Canizares JM Blanca JA Navarro E Monros F Palau MD Molto, Gene 2000 256 35 42 10.1016/S0378-1119(00)00343-7 11054533
102. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin. G Musco G Stier B Kolmerer S Adinolfi S Martin T Frenkiel T Gibson A Pastore, Structure Fold Des 2000 8 695 707 10.1016/S0969-2126(00) 00158-1 10903947
103. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. G De Michele A Filla F Cavalcanti L Di Maio L Pianese I Castaldo O Calabrese A Monticelli S Varrone G Campanella, J Neurol Neurosurg Psychiatry 1994 57 977 979 8057123
104. GAA trinucleotide repeat expansion in variant Friedreich's ataxia families. A Cruz-Martinez B Anciones F Palau, Muscle Nerve 1997 20 1121 1126 10.1002/(SICI)1097-4598(199709)20:9<1121::AID-MUS5>3.0.CO;2-A 9270667
105. Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to the Friedreich's ataxia locus on chromosome 9q. F Palau G De Michele JJ Vilchez M Pandolfo E Monros S Cocozza P Smeyers J Lopez-Arlandis G Campanella S Di Donato, Ann Neurol 1995 37 359 62 10.1002/ana.410370312 7695235
106. "Acadian" and "classical" forms of Friedreich ataxia are most probably caused by mutations at the same locus. BJ Keats LJ Ward J Shaw A Wickremasinghe S Chamberlain, Am J Med Genet 1989 33 266 268 10.1002/ajmg.1320330224 2764036
107. Intronic GAA triplet repeat expansion in Friedreich's ataxia presenting with pure sensory ataxia. J Berciano O Combarros M De Castro F Palau, J Neurol 1997 244 390 391 10.1007/s004150050109 9249627
108. Friedreich's ataxia presenting as adult-onset spastic paraparesis. PC Gates D Paris SM Forrest R Williamson RJ Gardner, Neurogenetics 1998 1 297 299 10.1007/s100480050045 10732807
109. Broadened Friedreich's ataxia phenotype after gene cloning. Minimal GAA expansion causes late-onset spastic ataxia. M Ragno G De Michele F Cavalcanti L Pianese A Monticelli L Curatola F Bollettini S Cocozza G Caruso L Santoro A Filla, Neurology 1997 49 1617 1620 9409356
110. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. MG Hanna MB Davis MG Sweeney M Noursadeghi CJ Ellis P Elliot NW Wood CD Marsden, Mov Disord 1998 13 339 340 10.1002/mds.870130223 9539351
111. Accuracy of clinical diagnostic criteria for Friedreich's ataxia. A Filla G De Michele G Coppola A Federico G Vita A Toscano A Uncini P Pisanelli P Barone V Scarano A Perretti L Santoro A Monticelli F Cavalcanti G Caruso S Cocozza, Mov Disord 2000 15 1255 1258 10.1002/1531-8257(200011)15:6<1255:: AID-MDS1031>3.0.CO;2-C 11104216
112. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. A Filla G De Michele F Cavalcanti L Pianese A Monticelli G Campanella S Cocozza, Am J Hum Genet 1996 59 554 560 8751856
113. Prenatal diagnosis of Friedreich ataxia: improved accuracy by using new genetic flanking markers. E Monros P Smeyers MA Ramos F Prieto F Palau, Prenat Diagn 1995 15 551 554 7659688
114. Prenatal diagnosis of Friedreich ataxia. M Pandolfo L Montermini, Prenat Diagn 1998 18 831 833 10.1002/(SICI)1097-0223(199808)18:8<831::AID- PD437>3.0.CO;2-N 9742572
115. Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. H Koutnikova V Campuzano M Koenig, Hum Mol Genet 1998 7 1485 1489 10.1093/hmg/7.9.1485 9700204
116. Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase. SS Branda P Cavadini J Adamec F Kalousek F Taroni G Isaya, J Biol Chem 1999 274 22763 22769 10.1074/jbc.274.32.22763 10428860
117. Friedreich ataxia: a paradigm for mitochondrial diseases. H Puccio M Koenig, Curr Opin Genet Dev 2002 12 272 277 10.1016/S0959-437X(02)00298-8 12076669
118. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. M Babcock D de Silva R Oaks S Davis-Kaplan S Jiralerspong L Montermini M Pandolfo J Kaplan, Science 1997 276 1709 1712 10.1126/science.276. 5319.1709 9180083
119. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. RB Wilson DM Roof, Nat Genet 1997 16 352 357 10.1038/ng0897-352 9241271
120. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. F Foury O Cazzalini, FEBS Lett 1997 411 373 377 10.1016/S0014-5793(97)00734-5 9271239
121. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. A Rotig P de Lonlay D Chretien F Foury M Koenig D Sidi A Munnich P Rustin, Nat Genet 1997 17 215 217 10.1038/ng1097-215 9326946
122. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. JL Bradley JC Blake S Chamberlain PK Thomas JM Cooper AH Schapira, Hum Mol Genet 2000 9 275 282 10.1093/hmg/9.2.275 10607838
123. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. J Adamec F Rusnak WG Owen S Naylor LM Benson AM Gacy G Isaya, Am J Hum Genet 2000 67 549 562 10930361 10.1086/303056
124. Physical evidence that yeast frataxin is an iron storage protein. O Gakh J Adamec AM Gacy RD Twesten WG Owen G Isaya, Biochemistry 2002 41 6798 6804 10.1021/bi025566+ 12022884
125. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. K C Chantrel-Groussard V Geromel H Puccio M Koenig A Munnich A Rotig P Rustin, Hum Mol Genet 2001 10 2061 2067 10.1093/hmg/10.19.2061 11590123
126. Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. S Jiralerspong B Ge TJ Hudson M Pandolfo, FEBS Lett 2001 509 101 105 10.1016/S0014-5793(01)03140-4 11734214
127. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. M Ristow MF Pfister AJ Yee M Schubert L Michael CY Zhang K Ueki MD Michael 2nd BB Lowell CR Kahn, Proc Natl Acad Sci USA 2000 97 12239 12243 11035806 10.1073/pnas.220403797
128. Cardiac iron deposits in Friedreich's ataxia. JB Lamarche D Shapcott M Cote B Lemieux, Handbook of Cerebellar Diseases New York: Marcel Dekker, Lechtenberg R, 1993 453 456
129. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia. MB Delatycki J Camakaris H Brooks T Evans-Whipp DR Thorburn R Williamson SM Forrest, Ann Neurol 1999 45 673 675 10.1002/1531-8249(199905)45: 5<673::AID-ANA20>3.0.CO;2-Q 10319894
130. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. A Wong J Yang P Cavadini C Gellera B Lonnerdal F Taroni G Cortopassi, Hum Mol Genet 1999 8 425 430 10.1093/hmg/8.3.425 9949201
131. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. M Cossee H Puccio A Gansmuller H Koutnikova A Dierich M LeMeur K Fischbeck P Dolle M Koenig, Hum Mol Genet 2000 9 1219 1226 10.1093/hmg/9.8.1219 10767347
132. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. H Puccio D Simon M Cossee P Criqui-Filipe F Tiziano J Melki C Hindelang R Matyas P Rustin M Koenig, Nat Genet 2001 27 181 186 10.1038/84818 11175786
133. A non-essential function for yeast frataxin in iron-sulfur cluster assembly. G Duby F Foury A Ramazzotti J Herrmann T Lutz, Hum Mol Genet 2002 11 2635 2643 10.1093/hmg/11.21.2635 12354789
134. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. U Muhlenhoff N Richhardt M Ristow G Kispal R Lill, Hum Mol Genet 2002 11 2025 2036 10.1093/hmg/11.17.2025 12165564
135. An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. J Gerber U Muhlenhoff R Lill, EMBO Rep 2003 4 906 911 12947415 10.1038/sj.embor.embor918
136. Mitochondrial functional interactions between frataxin and Isu1p, the iron-sulfur cluster scaffold protein, in Saccharomyces cerevisiae. A Ramazzotti V Vanmansart F Foury, FEBS Lett 2004 557 215 220 10.1016/S0014-5793(03)01498-4 14741370
137. Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. G Tan E Napoli F Taroni G Cortopassi, Hum Mol Genet 2003 12 1699 1711 10.1093/hmg/ddg187 12837693
138. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). E Lesuisse R Santos BF Matzanke SA Knight JM Camadro A Dancis, Hum Mol Genet 2003 12 879 889 10.1093/hmg/ddg096 12668611
139. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. AL Bulteau HA O'Neill MC Kennedy M Ikeda-Saito G Isaya LI Szweda, Science 2004 305 242 245 10.1126/science.1098991 15247478
140. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. R Lodi JM Cooper JL Bradley D Manners P Styles DJ Taylor AH Schapira, Proc Natl Acad Sci USA 1999 96 11492 11495 10500204 10.1073/pnas.96.20.11492
141. Frataxin interacts functionally with mithocondrial electron transport chain protein. P González-Cabo R Vázquez-Manrique MA García-Gimeno P Sanz F Palau, Hum Mol Genet 2005 14 2091 2098 10.1093/hmg/ddi214 15961414
142. Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant. RP Vazquez-Manrique P Gonzalez-Cabo S Ros H Aziz HA Baylis F Palau, Faseb J 2006 20 172 174 16293572
143. Friedreich ataxia: the oxidative stress paradox. H Seznec D Simon C Bouton L Reutenauer A Hertzog P Golik V Procaccio M Patel JC Drapier M Koenig H Puccio, Hum Mol Genet 2005 14 463 474 10.1093/hmg/ddi042 15615771
144. Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. RB Wilson DR Lynch KH Fischbeck, Ann Neurol 1998 44 132 134 10.1002/ana.410440121 9667602
145. Increased serum transferrin receptor concentrations in Friedreich ataxia. RB Wilson DR Lynch JM Farmer DG Brooks KH Fischbeck, Ann Neurol 2000 47 659 661 10.1002/1531-8249(200005)47:5<659::AID-ANA17>3.0.CO;2-T 10805340
146. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. P Rustin JC von Kleist-Retzow K Chantrel-Groussard D Sidi A Munnich A Rotig, Lancet 1999 354 477 479 10.1016/S0140-6736(99)01341-0 10465173
147. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. P Rustin A Rotig A Munnich D Sidi, Free Radic Res 2002 36 467 469 10.1080/10715760290021333 12069112
148. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. R Lodi PE Hart B Rajagopalan DJ Taylor JG Crilley JL Bradley AM Blamire D Manners P Styles AH Schapira JM Cooper, Ann Neurol 2001 49 590 596 10.1002/ana.1001 11357949
149. Oxidative stress in patients with Friedreich ataxia. JB Schulz T Dehmer L Schols H Mende C Hardt M Vorgerd K Burk W Matson J Dichgans MF Beal MB Bogdanov, Neurology 2000 55 1719 1721 11113228
150. Recombinant human erythropoietin: effects on frataxin expression in vitro. B Sturm D Stupphann C Kaun S Boesch M Schranzhofer J Wojta H Goldenberg B Scheiber-Mojdehkar, Eur J Clin Invest 2005 35 711 717 10.1111/j.1365-2362.2005. 01568.x 16269021
151. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. E Lamantea V Tiranti A Bordoni A Toscano F Bono S Servidei A Papadimitriou H Spelbrink L Silvestri G Casari GP Comi M Zeviani, Ann Neurol 2002 52 211 219 10.1002/ana.10278 12210792
152. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. M Rantamaki R Krahe A Paetau B Cormand I Mononen B Udd, Neurology 2001 57 1043 1049 11571332
153. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. G Van Goethem P Luoma M Rantamaki A Al Memar S Kaakkola P Hackman R Krahe A Lofgren JJ Martin P De Jonghe A Suomalainen B Udd C Van Broeckhoven, Neurology 2004 63 1251 1257 15477547
154. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. AH Hakonen S Heiskanen V Juvonen I Lappalainen PT Luoma M Rantamaki GV Goethem A Lofgren P Hackman A Paetau S Kaakkola K Majamaa T Varilo B Udd H Kaariainen LA Bindoff A Suomalainen, Am J Hum Genet 2005 77 430 441 16080118 10.1086/444548
155. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. G Van Goethem B Dermaut A Lofgren JJ Martin C Van Broeckhoven, Nat Genet 2001 28 211 212 10.1038/90034 11431686
156. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. RK Naviaux KV Nguyen, Ann Neurol 2004 55 706 712 10.1002/ana.20079 15122711
157. POLG mutations and Alpers syndrome. G Davidzon M Mancuso S Ferraris C Quinzii M Hirano HL Peters D Kirby DR Thorburn S DiMauro, Ann Neurol 2005 57 921 923 10.1002/ana.20498 15929042
158. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. G Ferrari E Lamantea A Donati M Filosto E Briem F Carrara R Parini A Simonati R Santer M Zeviani, Brain 2005 128 723 731 10.1093/brain/awh410 15689359
159. Digenic progressive external ophthalmoplegia in a sporadic patient: recessive mutations in POLG and C10orf2/Twinkle. G Van Goethem A Lofgren B Dermaut C Ceuterick JJ Martin C Van Broeckhoven, Hum Mutat 2003 22 175 176 10.1002/humu.10246 12872260
160. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. M Mancuso M Filosto M Bellan R Liguori P Montagna A Baruzzi S DiMauro V Carelli, Neurology 2004 62 316 318 14745080
161. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. RK Naviaux KV Nguyen, Ann Neurol 2005 58 491 10.1002/ana.20544 16130100
162. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. K Nikali A Suomalainen J Saharinen M Kuokkanen JN Spelbrink T Lonnqvist L Peltonen, Hum Mol Genet 2005 14 2981 1990 10.1093/hmg/ddi328 16135556
163. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. JN Spelbrink FY Li V Tiranti K Nikali QP Yuan M Tariq S Wanrooij N Garrido G Comi L Morandi L Santoro A Toscano GM Fabrizi H Somer R Croxen D Beeson J Poulton A Suomalainen HT Jacobs M Zeviani C Larsson, Nat Genet 2001 28 223 231 10.1038/90058 11431692
164. Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix-Saguenay in northeastern Quebec. M De Braekeleer F Giasson J Mathieu M Roy JP Bouchard K Morgan, Genet Epidemiol 1993 10 17 25 10.1002/gepi. 1370100103 8472930
165. Autosomal recessive disorders in Saguenay-Lac-Saint-Jean (Quebec, Canada): a study of inbreeding. M De Braekeleer S Gauthier, Ann Hum Genet 1996 60 51 56 8835098
166. Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. A Richter JD Rioux JP Bouchard J Mercier J Mathieu B Ge J Poirier D Julien G Gyapay J Weissenbach TJ Hudson SB Melancon K Morgan, Am J Hum Genet 1999 64 768 775 10053011 10.1086/302274
167. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): high-resolution physical and transcript map of the candidate region in chromosome region 13q11. JC Engert C Dore J Mercier B Ge C Betard JD Rioux C Owen P Berube K Devon B Birren SB Melancon K Morgan TJ Hudson A Richter, Genomics 1999 62 156 164 10.1006/geno.1999.6003 10610707
168. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. JC Engert P Berube J Mercier C Dore P Lepage B Ge JP Bouchard J Mathieu SB Melancon M Schalling ES Lander K Morgan TJ Hudson A Richter, Nat Genet 2000 24 120 125 10.1038/72769 10655055
169. Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia. G El Euch-Fayache I Lalani R Amouri I Turki K Ouahchi WY Hung S Belal T Siddique F Hentati, Arch Neurol 2003 60 982 988 10.1001/archneur.60.7.982 12873855
170. Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. GS Grieco A Malandrini G Comanducci V Leuzzi M Valoppi A Tessa S Palmeri L Benedetti A Pierallini S Gambelli A Federico F Pierelli E Bertini C Casali FM Santorelli, Neurology 2004 62 103 106 10.1159/000080451 14718707
171. A novel mutation in SACS gene in a family from southern Italy. C Criscuolo S Banfi M Orio P Gasparini A Monticelli V Scarano FM Santorelli A Perretti L Santoro G De Michele A Filla, Neurology 2004 62 100 102 14718706
172. Identification of a SACS gene missense mutation in ARSACS. T Ogawa Y Takiyama K Sakoe K Mori M Namekawa H Shimazaki I Nakano M Nishizawa, Neurology 2004 62 107 109 10.1159/000079841 14718708
173. Carlevoix-Saguenay type recessive spastic ataxia. A report of a Spanish case. I Pascual-Castroviejo SI Pascual-Pascual J Viano V Martinez, Rev Neurol 2000 31 36 38 10948580
174. Loss of function mutations in SIL1 cause Marinesco-Sjogren syndrome. JM Van Raamsdonk, Clin Genet 2006 69 399 400 10.1111/j.1399-0004.2006.00595a.x 16650075
175. Cerebellar ataxia, congenital cataracts, and retarded somatic and mental maturation. Report of cases of Marinesco-Sjogren syndrome. M Alter OR Talbert G Croffead, Neurology 1962 12 836 847 14012309
176. Genetic identity of Marinesco-Sjogren/myoglobinuria and CCFDN syndromes. L Merlini R Gooding H Lochmuller W Muller-Felber MC Walter D Angelicheva B Talim J Hallmayer L Kalaydjieva, Neurology 2002 58 231 236 11805249
177. Linkage to 18qter differentiates two clinically overlapping syndromes: congenital cataracts-facial dysmorphism-neuropathy (CCFDN) syndrome and Marinesco-Sjogren syndrome. C Lagier-Tourenne D Chaigne J Gong J Flori M Mohr D Ruh D Christmann J Flament JL Mandel M Koenig H Dollfus, J Med Genet 2002 39 838 843 10.1136/jmg.39.11.838 12414825
178. Homozygosity mapping of Marinesco-Sjogren syndrome to 5q31. C Lagier-Tourenne L Tranebaerg D Chaigne M Gribaa H Dollfus G Silvestri C Betard JM Warter M Koenig, Eur J Hum Genet 2003 11 770 778 10.1038/sj.ejhg.5201068 14512967
179. The gene disrupted in Marinesco-Sjogren syndrome encodes SIL1, an HSPA5 cochaperone. AK Anttonen I Mahjneh RH Hamalainen C Lagier-Tourenne O Kopra L Waris M Anttonen T Joensuu H Kalimo A Paetau L Tranebjaerg D Chaigne M Koenig O Eeg-Olofsson B Udd M Somer H Somer AE Lehesjoki, Nat Genet 2005 37 1309 1311 10.1038/ng1677 16282978
180. Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. J Senderek M Krieger C Stendel C Bergmann M Moser N Breitbach-Faller S Rudnik-Schoneborn A Blaschek NI Wolf I Harting K North J Smith F Muntoni M Brockington S Quijano-Roy F Renault R Herrmann LM Hendershot JM Schroder H Lochmuller H Topaloglu T Voit J Weis F Ebinger K Zerres, Nat Genet 2005 37 1312 1314 10.1038/ng1678 16282977
181. Early onset cerebellar ataxia with retained tendon reflexes: a clinical and genetic study of a disorder distinct from Friedreich's ataxia. AE Harding, J Neurol Neurosurg Psychiatry 1981 44 503 508 7276963
182. Early-onset cerebellar ataxia with retained tendon reflexes. A Ozeren N Arac A Ulku, Acta Neurol Scand 1989 80 593 597 2618587
183. Clinical and genetic heterogeneity in early onset cerebellar ataxia with retained tendon reflexes. A Filla G De Michele F Cavalcanti A Perretti L Santoro F Barbieri G D'Arienzo G Campanella, J Neurol Neurosurg Psychiatry 1990 53 667 670 2213043
184. Early onset cerebellar ataxia with retained tendon reflexes. Clinical, electrophysiological and MRI observations in comparison with Friedreich's ataxia. T Klockgether D Petersen W Grodd J Dichgans, Brain 1991 114 1559 1573 1884166
185. Early onset cerebellar ataxia with retained tendon reflexes: prevalence and gene frequency in an Italian population. A Chio L Orsi P Mortara D Schiffer, Clin Genet 1993 43 207 211 8330454
186. Early onset cerebellar ataxia and preservation of tendon reflexes: clinical phenotypes associated with GAA trinucleotide repeat expanded and non-expanded genotypes. M De Castro A Cruz-Martinez JJ Vilchez T Sevilla M Pineda J Berciano F Palau, J Peripher Nerv Syst 1999 4 58 62 10197066
187. Early-onset cerebellar ataxia with retained tendon reflexes. A Filla G De Michele, Handbook of Ataxia Disorders New York: Marcel Dekker, Inc, Klockgether T, 2000 191 204
188. Cerebellar ataxia and coenzyme Q10 deficiency. C Lamperti A Naini M Hirano DC De Vivo E Bertini S Servidei M Valeriani D Lynch B Banwell M Berg T Dubrovsky C Chiriboga C Angelini E Pegoraro S DiMauro, Neurology 2003 60 1206 1208 12682339
189. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. O Musumeci A Naini AE Slonim N Skavin GL Hadjigeorgiou N Krawiecki BM Weissman CY Tsao JR Mendell S Shanske DC De Vivo M Hirano S DiMauro, Neurology 2001 56 849 855 11294920
190. Cerebellar ataxia with coenzyme Q(10) deficiency: Diagnosis and follow-up after coenzyme Q(10) supplementation. R Artuch G Brea-Calvo P Briones A Aracil M Galvan C Espinos J Corral V Volpini A Ribes AL Andreu F Palau JA Sanchez-Alcazar P Navas M Pineda, J Neurol Sci 2006 246 153 158 10.1016/j.jns.2006.01.021 16677673
191. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. CM Quinzii AG Kattah A Naini HO Akman VK Mootha S DiMauro M Hirano, Neurology 2005 64 539 541 15699391
192. An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa. JJ Higgins DH Morton N Patronas LE Nee, Neurology 1997 49 1717 1720 9409377
193. Autosomal recessive posterior column ataxia and retinitis pigmentosa. J Berciano JM Polo, Neurology 1998 51 1772 1773 9855554
194. Posterior column ataxia and retinitis pigmentosa: a distinct clinical and genetic disorder. JJ Higgins K Kluetzman J Berciano O Combarros JM Loveless, Mov Disord 2000 15 575 578 10.1002/1531-8257(200005)15:3<575::AID- MDS1023>3.0.CO;2-7 10830426
195. Posterior column ataxia with retinitis pigmentosa (AXPC1) maps to chromosome 1q31-q32. JJ Higgins DH Morton JM Loveless, Neurology 1999 52 146 150 9921862
196. Prevalence of hereditary motor and sensory neuropathy in Cantabria. O Combarros J Calleja JM Polo J Berciano, Acta Neurol Scand 1987 75 9 12 3472423
197. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. A Rotig EL Appelkvist V Geromel D Chretien N Kadhom P Edery M Lebideau G Dallner A Munnich L Ernster P Rustin, Lancet 2000 356 391 395 10.1016/S0140-6736(00)02531-9 10972372
198. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. S Di Giovanni M Mirabella A Spinazzola P Crociani G Silvestri A Broccolini P Tonali S Di Mauro S Servidei, Neurology 2001 57 515 518 11502923
199. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol. MG Traber R Ramakrishnan HJ Kayden, Proc Natl Acad Sci USA 1994 91 10005 10008 7937827 10.1073/pnas.91.21.10005
200. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. MG Traber RJ Sokol GW Burton KU Ingold AM Papas JE Huffaker HJ Kayden, J Clin Invest 1990 85 397 407 2298915
201. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. MG Traber RJ Sokol A Kohlschutter T Yokota DP Muller R Dufour HJ Kayden, J Lipid Res 1993 34 201 210 8429255
202. Abetalipoproteinaemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. E Azizi JL Zaidman J Eshchar A Szeinberg, Acta Paedia Scand 1978 67 797 801
203. Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia. DP Muller JK Lloyd, Ann N Y Acad Sci 1982 393 133 144 6959555
204. Long-term management of abetalipoproteinaemia. Possible role for vitamin E. DP Muller JK Lloyd AC Bird, Arch Dis Child 1977 52 209 214 848999
205. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use. M Kuriyama Y Tokimura J Fujiyama Y Utatsu M Osame, J Neurol Sci 1994 125 22 28 10.1016/0022-510X(94)90237-2 7964884
206. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. G Salen V Berginer V Shore I Horak E Horak GS Tint S Shefer, N Engl J Med 1987 316 1233 1238 3106810
207. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. VM Berginer G Salen S Shefer, N Engl J Med 1984 311 1649 1652 6504105